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lary or Hurthle cell tumours as well as in the obviously follicular variety. Thus it seems likely that radioiodine treatment will be useful in something like 40% of suitable patients, i.e. of those who are well enough and who have inoperable or metastatic well-differentiated thyroid cancer.
In this group of patients, benefit from treatment can be clearly seen. In survival we have 4 patients out of 6 in Stages 1 and 2 alive at five years, and 6 out of 10 in Stages 3 and 4, compared with average survival in all treated patients with differentiated cancer of 55 % Stage 2 and 30 % Stages 3 and 4. Benefit is also seen earlier, in shrinkage of masses in the neck and elsewhere, radiological disappearance of lung metastases, and recalcification ofbone metastases. (Case histories were given showing these and other aspects.)
Hormone treatment has been used more widely during the last five years but it should be emphasized that long-term survival is quite possible without it. Most of the long-term survivors after X-ray therapy at Manchester have not, in the past, been given thyroid hormone.
Occasional cases, however, have clearly demonstrated the effect of thyroid hormone; the following history is one example: Case 3 (53/4478) Woman aged 62 Seen in 1953 with a past history of subtotal thyroidectomy five years before for a goitre that had then been present for fifteen years. A swelling had again appeared in the neck eight months before. A biopsy now showed differentiated follicular adenocarcinoma, and chest X-ray showed lung metastases. The patient was given X-ray treatment to the neck, and three successive treatment doses of radioiodine. The chest X-ray appearances did not change much, however, until suddenly, between January and April 1955, four and seven months after the last radioiodine, there was what the radiologist called 'a dramatic improvement'. Review of the history showed that this coincided with an increase in thyroid administration from gr A to gr 2 daily. The lungs remained clear for a year, when there was death from cardiac failure.
Although Dunhill reported two cases in 1937, it was only after Balme (1954) in this country and Ward (1955) in the United States reported single cases that the value of hormone treatment came to be recognized widely. There is an analogy with breast cancer, a tumour with wide histological variation and a correspondingly variable range of speed of growth and metastasis. In breast cancer hormone treatment is often very effective, but it is difficult to predict its value with certainty in an individual patient, and the effect may be only temporary, as has already been seen in thyroid cancer in the cases reported here and by Thomas & Burns (1961) .
The sensible decision is that hormone treatment, usually sodium L-thyroxine, in maximal tolerated dosage, commonly 0-3 or 04 mg daily, should be given to all patients with thyroid cancer whether or not there be any symptoms of hypothyroidism, and that whatever other treatment be advisablesurgery, X-ray therapy or radioiodineshould still be given.
In conclusion, radiotherapy should be tried for most patients with thyroid cancer which is inoperable or recurrent or residual after operation, or in which there are distant metastases; X-ray therapy can be used for most histological types, but especially for undifferentiated tumours, particularly malignant lymphoma; radioactive iodine is usually only applicable to a proportion of differentiated carcinomas. Thyroid hormone treatment should be given in addition to and not as a substitute for surgery and radiotherapy.
Mr R S Murley (London) deplored the tendency of many authorities to advocate total thyroidectomy for all cases in which surgery was undertaken. He believed that there was littlejustification in so dogmatic an approach. In cases of welldifferentiated papillary carcinoma hemithyroidectomy with partial resection of the opposite lobe was often adequate, safer and more satisfactory. Whatever might be the views of a few highly experienced thyroid surgeons it was as well to remember that many of these cases would be handled by men of lesser experience. For this reason he suggested that it was more intelligent to avoid wholesale total thyroidectomy, and to encourage the surgeon to act according to his experience and judgment when the gland was fully exposed at operation. Mr Murley did not deny the occurrence of multicentric tumours, but he stated that such cases should not be allowed to colour the whole approach to thyroid carcinoma.
